Patent · US Expired

Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use

US5831004A · kind A · utility

8Cited by
24References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 1995
Grant dateNov 3, 1998
Priority date
Expiry dateOct 27, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/14
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed are novel inhibitors of metalloproteases, in particular matrix metalloproteases. The disclosed inhibitors are mercaptoketone and mercaptoalcohol compounds which are useful in pharmaceutical compositions and methods for treating or controlling disease states or conditions which involve tissue breakdown, for example, arthropathy, dermatological conditions, bone resorption, inflammatory diseases, and tumor invasion and in the promotion of wound healing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.